Clinical trial
Intermittent and Daily Dosing for Episodic (Periodic) Asthma…
NCT00337675 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00337675 |
|---|---|
| Title | Intermittent and Daily Dosing for Episodic (Periodic) Asthma (0476-302)(COMPLETED) |
| Official title | A Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Study Evaluating the Effects of 2 Different Regimens of Montelukast (Daily Dosing and Intermittent, Episode-Driven Dosing) Compared With Placebo in the Treatment of Episodic Asthma in Children Aged 6 Months to 5 Years |
| Lead sponsor | Organon and Co, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | montelukast sodium, Comparator: Placebo (unspecified) |
| Enrollment | 1,771 |
| Start date | Oct 1, 2006 |
| Primary completion | Aug 1, 2009 |
| Completion | Aug 1, 2009 |
| First posted | Jun 16, 2006 |
| Last update posted | May 10, 2024 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: